Abstract
The difficulty to recognize lymphatic vessels in common histological sections, particularly when they are collapsed, as they very often do, has long hampered research on lymphatics in spite of their universally accepted importance in tissue homeostasis, inflammation, immunity, and tumor spreading. The only positive identification criteria were the ultrastructural detection of a discontinuous basement membrane and anchoring filaments. Two recent discoveries have dramatically changed the interest of the scientific community in this long neglected field: the discovery of lymphatic-specific growth factors (vascular endothelial growth factor C and D) and the discovery of lymphatic markers (vascular endothelial growth factor receptor 3, Lyve-1, Prox1, and podoplanin). The role of lymphatics in several pathological conditions has so been elucidated, opening the possibility of new therapeutic strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A. 1995;92:3566–70.
Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J. 1996;15:290–8.
Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276:1423–5.
Irrthum A, Karkkainen MJ, Devriendt K, et al. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet. 2000;67:295–301.
Karkkainen MJ, Ferrell RE, Lawrence EC, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000;25:153–9.
Sleeman JP, Krishnan J, Kirkin V, et al. Markers for the lymphatic endothelium: in search of the holy grail? Microsc Res Tech. 2001;55:61–9.
Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98:769–78.
Hong YK, Harvey N, Noh YH, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn. 2002;225:351–7.
Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144:789–801.
Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest. 2002;82:1255–7.
Schacht V, Dadras SS, Johnson LA, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166:913–21.
Schacht V, Ramirez MI, Hong YK, et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. Embo J. 2003;22:3546–56.
Sabin FR. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat. 1902;1:367–91.
Detmar M, Hirakawa S. The formation of lymphatic vessels and its importance in the setting of malignancy. J Exp Med. 2002;196:713–8.
Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946–53.
Petrova TV, Karpanen T, Norrmén C, et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med. 2004;10:974–81.
Goldman J, Rutkowski JM, Shields JD, et al. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. Faseb J. 2007;21:1003–12.
Kajiya K, Hirakawa S, Ma B, et al. Hepatocyte growth factor promotes lymphatic vessel formation and function. Embo J. 2005;24:2885–95.
Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115:2363–72.
Hirakawa S, Kodama S, Kunstfeld R, et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med. 2005;201:1089–99.
Baluk P, Fuxe J, Hashizume H, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204:2349–62.
Sacchi G, Weber E, Aglianò M, et al. The structure of superficial lymphatics in the human thigh: precollectors. Anat Rec. 1997;247:53–62.
Sacchi G, Weber E, Aglianò M, et al. Lymphatic vessels of the human heart: precollectors and collecting vessels. A morpho-structural study. J Submicrosc Cytol Pathol. 1999;31:515–25.
Leak LV, Burke JF. Fine structure of the lymphatic capillary and the adjoining connective tissue area. Am J Anat. 1966;118:785–809.
Casley Smith JR. Are the initial lymphatics normally pulled open by anchoring filaments? Lymphology. 1980;13:120–9.
Gerli R, Ibba L, Fruschelli C. Ultrastructural cytochemistry of anchoring filaments of human lymphatic capillaries and their relation to elastic fibers. Lymphology. 1991;24:105–12.
Kielty CM, Wess TJ, Haston L, et al. Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix. J Muscle Res Cell Motil. 2002;23:581–96.
Ramirez F, Sakai LY. Biogenesis and function of fibrillin assemblies. Cell Tissue Res. 2010;339:71–82.
Gerli R, Ibba L, Fruschelli C. A fibrillar elastic apparatus around human lymph capillaries. Anat Embryol. 1990;181:281–6.
Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 1986;103:2499–509.
Weber E, Rossi A, Solito R, et al. Focal adhesion molecules expression and fibrillin deposition by lymphatic and blood vessel endothelial cells in culture. Microvasc Res. 2002;64:47–55.
Weber E, Rossi A, Gerli R, et al. Micropatterned hyaluronan surfaces promote lymphatic endothelial cell alignment and orient their growth. Lymphology. 2004;37:15–21.
Rossi A, Weber E, Sacchi G, et al. Mechanotransduction in lymphatic endothelial cells. Lymphology. 2007;40:102–13.
Burridge K, Turner CE, Romer LH. Tyrosine phosphorylation of paxillin and pp 125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol. 1992;119:893–903.
Schaller MD, Borgman CA, Cobb BS, et al. pp 125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A. 1992;89:5192–6.
Rubinfeld H, Seger R. The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol. 2005;31:151–74.
Sun HW, Li CJ, Chen HQ, et al. Involvement of integrins, MAPK, and NF-kappaB in regulation of the shear stress-induced MMP-9 expression in endothelial cells. Biochem Biophys Res Commun. 2007;353:152–8.
Coulthard LR, White DE, Jones DL, et al. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med. 2009;15:369–79.
Choi JJ, Min DJ, Cho ML, et al. Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol. 2003;30:1529–33.
Distler O, Del Rosso A, Giacomelli R, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002;4:R11.
Distler O, Distler JH, Scheid A, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res. 2004;95:109–16.
Cutolo M, Pizzorni C, Tuccio M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology. 2004;43:719–26.
Chitale S, Al-Mowallad AF, Wang Q, et al. High circulating levels of VEGF-C suggest abnormal lymphangiogenesis in systemic sclerosis. Rheumatology (Oxford). 2008;47:1727–8.
Leu AJ, Gretener SB, Enderlin S, et al. Lymphatic microangiopathy of the skin in systemic sclerosis. Rheumatology (Oxford). 1999;38:221–7.
Rossi A, Sozio F, Sestini P, et al. Lymphatic and blood vessels in scleroderma skin, a morphometric analysis. Hum Pathol. 2010;40:366–74.
Oka M, Iwata C, Suzuki HI, et al. Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood. 2008;111:4571–9.
Clavin NW, Avraham T, Fernandez J, et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol. 2008;295:H2113–27.
Tanaka T, Damião AO, Gabriel Júnior A, et al. Protein-losing enteropathy in systemic lupus erythematosus. Rev Hosp Clin Fac Med Sao Paulo. 1991;46:34–7.
Pruim B, Strutton G, Congdon S, et al. Cutaneous histiocytic lymphangitis: an unusual manifestation of rheumatoid arthritis. Australas J Dermatol. 2000;41:101–5.
Takiwaki H, Adachi A, Kohno H, et al. Intravascular or intralymphatic histiocytosis associated with rheumatoid arthritis: a report of 4 cases. J Am Acad Dermatol. 2004;50:585–90.
Jurisic G, Detmar M. Lymphatic endothelium in health and disease. Cell Tissue Res. 2009;335:97–108.
Tammela T, Zarkada G, Wallgard E, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature. 2008;454:656–60.
Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14:1890–5.
Casabona F, Bogliolo S, Ferrero S, et al. Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol. 2008;15:3318–9.
Shin’oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med. 2001;344:532–3.
Matsumura G, Hibino N, Ikada Y, et al. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials. 2003;24:2303–8.
Pasqui D, Rossi A, Barbucci R, et al. Hyaluronan and sulphated hyaluronan micropatterns: effect of chemical and topographic cues on lymphatic endothelial cell alignment and proliferation. Lymphology. 2005;38:50–65.
Rossi A, Pasqui D, Barbucci R, et al. The topography of microstructured surfaces differently affects fibrillin deposition by blood and lymphatic endothelial cells in culture. Tissue Eng Part A. 2009;15:525–33.
Acknowledgments
We wish to thank D.J. Abraham, C.P. Denton, K. Khan (UCL Medical School, London), E.A. Renzoni (Royal Brompton Hospital, London), and P. Sestini (University of Siena) for their collaboration in the study of lymphatic vessels in scleroderma skin.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London Limited
About this chapter
Cite this chapter
Weber, E., Sozio, F., Gabbrielli, E., Rossi, A. (2012). Lymphatic Vessels in Health and Disease. In: Abraham, D., Handler, C., Dashwood, M., Coghlan, G. (eds) Translational Vascular Medicine. Springer, London. https://doi.org/10.1007/978-0-85729-920-8_9
Download citation
DOI: https://doi.org/10.1007/978-0-85729-920-8_9
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-919-2
Online ISBN: 978-0-85729-920-8
eBook Packages: MedicineMedicine (R0)